Researchers say they won't be able to return to facilities for years; findings can potentially lead to blood test that could ...

AGC Biologics will commence cell therapy process development and clinical manufacturing services at AGC Inc.’s Yokohama ...

Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields.

Mesenchymal stem cells (MSCs), which can be harvested from fat and bone marrow, have immune-modulating and anti-inflammatory ...

Imagine a world where blood type no longer dictates life-saving transfusions. A future where emergency responders don't need ...

Japan’s stem cell push isn’t just about mending hearts, or bodies. To reprogram a cell is to reprogram decline. For a nation wrestling with age, stagnation, ...

One study, which treated 12 patients in the U.S. and Canada, used stem cells from donated human embryos, while the other study injected seven patients with donated adult stem cells in Kyoto, Japan.

Shinya Yamanaka, a professor at Kyoto University in Japan who won the Nobel Prize in Physiology or Medicine in 2012. He pioneered the induced pluripotent stem cell (iPSc) technology that converts ...

Dopamine neuronal precursor cells made from embryonic stem cells are administered to Parkinson's disease patients. After 18 months of follow-up, no significant side effects occurred.

Japan’s big bet on stem-cell therapies might soon pay off with medical breakthroughs. Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more.

They replicated the Japanese experiment: when hydrogels carry medicine directly to CSCs, they can also grow and identify CSCs by transforming regular cancer cells into stem-like ones.